| Business Summary | | Specialty
Laboratories,
Inc.
is
a
research-based
clinical
laboratory
predominantly
focused
on
developing
and
performing
esoteric
clinical
laboratory
tests,
which
the
Company
refers
to
as
assays.
The
Company
offers
more
than
3,500
esoteric
assays,
many
of
which
have
been
developed
through
its
internal
research
and
development
efforts.
Esoteric
assays
are
complex,
comprehensive
or
unique
tests
used
to
diagnose,
evaluate
and
monitor
patients.
These
assays
are
often
performed
on
sophisticated
instruments
by
highly
skilled
personnel,
and
are
therefore
offered
by
a
limited
number
of
clinical
laboratories.
Two
of
the
Company's
thousands
of
esoteric
assays
include
GenotypR,
its
assays
for
predicting
resistance
to
HIV,
and
ANAlyzer,
its
assays
used
to
help
diagnose
complex
autoimmune
disorders.
The
Company
performs
all
of
its
testing
services
at
its
laboratory
facility
in
Santa
Monica,
California. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Specialty
Laboratories
Inc.
is
a
research-based
clinical
laboratory
focused
predominantly
on
developing
and
performing
esoteric
clinical
laboratory
tests.
For
the
six
months
ended
6/30/01,
revenues
increased
20%
to
$89
million.
Net
income
increased
57%
to
$6.6
million.
Revenues
reflect
increased
accessions
due
to
a
growth
in
existing
core
business
and
the
acquisition
of
the
assets
of
BBI
Clinical
Laboratories.
Net
income
also
reflects
improved
efficiencies. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| James Peter, M.D., Ph.D, 67 Chairman,
CEO | $900K | Paul Beyer, 41 Pres,
COO, Director | 543K | Frank Spina, 46 CFO | 245K | Shoji Maruyama, 60 Sr.
VP | -- | Bart Thielen, 36 VP-Fin.,
Treasurer | 231K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|